Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29950014 | 0.92 | — | — | |
| SCHEMBL10479233 | 0.90 | — | — | |
| SCHEMBL5579 | 0.83 | — | — | |
| SCHEMBL9332388 | 0.83 | ALOX15 (0.39) | ALOX15 | |
| SCHEMBL28558592 | 0.82 | — | — | |
| Hydrochloric Acid SCHEMBL1958678 | 0.81 | — | — | |
| SCHEMBL28773506 | 0.78 | — | — | |
| SCHEMBL29059132 | 0.76 | ALDH1A1 (0.39) | ALOX15 | |
| SCHEMBL12455815 | 0.74 | ALOX15 (0.35) | ALOX15 | |
| SCHEMBL6701636 | 0.74 | ALOX15 (0.32) | ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111278840-B | Pyrrolo [2,3-B ] pyridine compounds and their use for the treatment of cancer | 癌症研究科技有限公司 | 2023-11-17 | — | — | CN | disclosed |
| US-11447505-B1 | Pyrrolo[2,3-b]pyridine compounds and their use in the treatment of cancer | CANCER RESEARCH TECHNOLOGY LIMITED (GB) | 2022-09-20 | — | — | US | disclosed |
| US-11427578-B1 | Substituted pyrrolopyridine-derivatives | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2022-08-30 | — | — | US | disclosed |
| EP-3668882-A1 | PYRROLO[2,3-B]PYRIDINE COMPOUNDS AND THEIR USE IN THE TREATMENT OF CANCER | Cancer Research Technology Limited (GB) | 2020-06-24 | — | — | EP | disclosed |
| CN-111278840-A | Pyrrolo [2, 3-B ] pyridine compounds and their use for treating cancer | 癌症研究科技有限公司 | 2020-06-12 | — | — | CN | disclosed |
| EP-3655406-A1 | SUBSTITUTED PYRROLOPYRIDINE-DERIVATIVES | Bayer Pharma Aktiengesellschaft (DE) | 2020-05-27 | — | — | EP | disclosed |
| WO-2019034890-A1 | PYRROLO[2,3-B]PYRIDINE COMPOUNDS AND THEIR USE IN THE TREATMENT OF CANCER | CANCER RESEARCH TECHNOLOGY LIMITED (GB) | 2019-02-21 | — | — | WO | disclosed |
| WO-2019016071-A1 | SUBSTITUTED PYRROLOPYRIDINE-DERIVATIVES | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2019-01-24 | — | — | WO | disclosed |
| EP-1799694-B1 | METHOD OF PRODUCING SILYLALKOXYMETHYL HALIDE | DOW CORNING TORAY CO LTD (JP) | 2012-05-09 | — | — | EP | disclosed |
| US-7915439-B2 | Method of producing silylalkoxymethyl halide | DOW CORNING TORAY COMPANY, LTD. (JP) | 2011-03-29 | — | — | US | disclosed |
| US-20090203932-A1 | Method of Producing Silylalkoxymethyl Halide | DOW CORNING TORAY CO., LTD. (JP) | 2009-08-13 | — | — | US | disclosed |
| EP-1799694-A1 | METHOD OF PRODUCING SILYLALKOXYMETHYL HALIDE | Dow Corning Toray Co., Ltd. (JP) | 2007-06-27 | — | — | EP | disclosed |
| WO-2006040964-A1 | METHOD OF PRODUCING SILYLALKOXYMETHYL HALIDE | DOW CORNING TORAY CO., LTD. (JP) | 2006-04-20 | — | — | WO | disclosed |
| US-4868189-A | ANTICANCER AGENTS | SANWA KAGAKU KENKYUSHO CO. (JP) | 1989-09-19 | — | — | US | disclosed |
| EP-0280841-A2 | Organo-silicone compounds and use thereof | SANWA KAGAKU KENKYUSHO CO., LTD. (JP) | 1988-09-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090203932-A1 | Method of Producing Silylalkoxymethyl Halide | CBR3, CBR1, HRH3 | ALOX15 4481/4885 |
| US-11447505-B1 | Pyrrolo[2,3-b]pyridine compounds and their use in the treatment of cancer | PDXK, CCNK, CDC42BPB | ALOX15 3317/4885 |
| US-11427578-B1 | Substituted pyrrolopyridine-derivatives | MAP3K4, MAP4K4, MAP4K3 | ALOX15 4363/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.